Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$31.00
+4.91%today
MKT CAP
$493M
+4.7% · 1Y
Earnings History
+26.9%
+23.1%
-10.2%
+392.9%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$31.00
Low
$40.00
Analyst Mean
$48.75
High
$62.00
4 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-13.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+293.6%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership32.4%
Institutional Ownership59.8%
Short % of Float14.14%
Days to Cover18.9d
1 Week+6.6%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BJORKQUIST JEANETTE M | Officer | Sale | 328 | $26.65 | $0.01M | 2026-03-30 |
| WHITE NICOLE S | Officer | Sale | 197 | $26.65 | $0.01M | 2026-03-30 |
| OKAZAKI JASON A | Chief Executive Officer | Stock | 94,250 | $0.00 | $0.00M | 2026-03-27 |
| DELANEY WILLIAM E IV | Officer | Stock | 26,000 | $0.00 | $0.00M | 2026-03-27 |
| BJORKQUIST JEANETTE M | Officer | Stock | 6,500 | $0.00 | $0.00M | 2026-03-27 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Gilead Sciences Inc | institution | 28.35% | $0.14B | +0.00% | 2025-12-31 |
| Farallon Capital Management LLC | institution | 7.72% | $0.04B | +0.00% | 2025-12-31 |
| RA Capital Management, L.P. | institution | 6.42% | $0.03B | +0.00% | 2025-12-31 |
| Commodore Capital Lp | institution | 6.29% | $0.03B | +0.00% | 2025-12-31 |
| Janus Henderson Group PLC | institution | 5.27% | $0.03B | +11.33% | 2025-12-31 |
| Paradigm Biocapital Advisors LP | institution | 4.19% | $0.02B | +100.00% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 3.78% | $0.02B | +102.90% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.60% | $0.02B | +14.10% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.19% | $0.01B | +18.91% | 2025-12-31 |
| Blackstone Inc | institution | 2.01% | $0.01B | -28.82% | 2025-12-31 |
| Parkman Healthcare Partners LLC | institution | 1.57% | $0.01B | -0.65% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.78% | $0.00B | +1.84% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.37% | $0.00B | -0.36% | 2026-02-28 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | fund | 0.19% | $0.00B | -66.68% | 2026-01-31 |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Growth Fund | fund | 0.16% | $0.00B | +0.00% | 2026-01-31 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.14% | $0.00B | -8.59% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.13% | $0.00B | +0.00% | 2026-02-28 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | fund | 0.11% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | fund | 0.11% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.06% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ASMB.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.